UB Paderborn / Katalog / Suche / in CDI

EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, 2019-12, Vol.15 (11), p.e990

2019

Link zum Volltext

Verfügbarkeit prüfen

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

The Lancet (British edition), 2018-09, Vol.392 (10151), p.940-949

2018

Link zum Volltext

Verfügbarkeit prüfen

Embolization of left atrial appendage closure devices: A systematic review of cases reported with the watchman device and the amplatzer cardiac plug

Catheterization and cardiovascular interventions, 2015-07, Vol.86 (1), p.128-135

2015

Link zum Volltext

Verfügbarkeit prüfen

Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting

Journal of the American College of Cardiology, 2019-11, Vol.74 (18), p.2223-2234

2019

Link zum Volltext

Verfügbarkeit prüfen

COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

Heart (British Cardiac Society), 2022-03, Vol.108 (6), p.458

2022

Link zum Volltext

Verfügbarkeit prüfen

THREE-YEAR OUTCOME OF ALL-COMER PATIENTS TREATED WITH RESOLUTE ONYX ZOTAROLIMUS-ELUTING VERSUS ORSIRO SIROLIMUS-ELUTING STENTS IN THE RANDOMIZED BIONYX TRIAL

Journal of the American College of Cardiology, 2021-05, Vol.77 (18), p.1026-1026

2021

Link zum Volltext

Verfügbarkeit prüfen

Azygos continuation of the inferior vena cava during transvenous cardiac interventions

Acta Cardiologica, 2014-08, Vol.69 (4), p.456-457

2014

Link zum Volltext

Verfügbarkeit prüfen

Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent

Catheterization and cardiovascular interventions, 2024-05

2024

Link zum Volltext

Verfügbarkeit prüfen

Non-invasive follow-up of a coronary artery pseudoaneurysm after percutaneous transluminal coronary rotational atherectomy (PTCRA)

Acta Cardiologica, 2013-06, Vol.68 (3), p.319-323

2013

Link zum Volltext

Verfügbarkeit prüfen

Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials

Atherosclerosis, 2022-08, Vol.355, p.52-59

2022

Link zum Volltext

Verfügbarkeit prüfen

Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation

International journal of cardiology, 2016-03, Vol.207, p.335-340

2016

Link zum Volltext

Verfügbarkeit prüfen

Hemolysis after percutaneous paravalvular leak repair

Acta clinica belgica (English ed. Online), 2016-10, Vol.71 (5), p.316-318

2016

Link zum Volltext

Verfügbarkeit prüfen

Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease

International journal of cardiology, 2023-03, Vol.374, p.27-32

2023

Link zum Volltext

Verfügbarkeit prüfen

Menü

Weitere Dienste

Einstellungen

Impact of long-term ticagrelor monotherapy following 1-month dual antiplatelet therapy in patients who underwent complex percutaneous coronary intervention: insights from the Global Leaders trial

First Report of 3-Year Clinical Outcome After Treatment With Novel Resolute Onyx Stents in the Randomized BIONYX Trial

Thin Composite-Wire-Strut Zotarolimus-Eluting Stents Versus Ultrathin-Strut Sirolimus-Eluting Stents in BIONYX at 2 Years

Efficacy and Safety of Ticagrelor Monotherapy by Clinical Presentation: Pre-Specified Analysis of the GLOBAL LEADERS Trial

Impact of prediabetes and diabetes on 3-year outcome of patients treated with new-generation drug-eluting stents in two large-scale randomized clinical trials

Clinical results after hybrid coronary revascularization with totally endoscopic coronary surgery

Ticagrelor Monotherapy or Dual Antiplatelet Therapy After Drug-Eluting Stent Implantation: Per-Protocol Analysis of the GLOBAL LEADERS Trial

Impact of premature coronary artery disease on adverse event risk following first percutaneous coronary intervention

Impact of recruitment and retention on all-cause mortality in a large all-comers randomised controlled trial: insights from the GLOBAL LEADERS trial

Final results of the HEALING IIB trial to evaluate a bio-engineered CD34 antibody coated stent (Genous™Stent) designed to promote vascular healing by capture of circulating endothelial progenitor cells in CAD patients

Final results of the randomised evaluation of short-term dual antiplatelet therapy in patients with acute coronary syndrome treated with a new-generation stent (REDUCE trial)

Ticagrelor plus aspirin for 1 month, followed by ticagrelor monotherapy for 23 months vs aspirin plus clopidogrel or ticagrelor for 12 months, followed by aspirin monotherapy for 12 months after implantation of a drug-eluting stent: a multicentre, open-label, randomised superiority trial

Embolization of left atrial appendage closure devices: A systematic review of cases reported with the watchman device and the amplatzer cardiac plug

Ticagrelor Alone Versus Dual Antiplatelet Therapy From 1 Month After Drug-Eluting Coronary Stenting

Thin composite wire strut, durable polymer-coated (Resolute Onyx) versus ultrathin cobalt–chromium strut, bioresorbable polymer-coated (Orsiro) drug-eluting stents in allcomers with coronary artery disease (BIONYX): an international, single-blind, randomised non-inferiority trial

COVID-19 pandemic, mechanical reperfusion and 30-day mortality in ST elevation myocardial infarction

THREE-YEAR OUTCOME OF ALL-COMER PATIENTS TREATED WITH RESOLUTE ONYX ZOTAROLIMUS-ELUTING VERSUS ORSIRO SIROLIMUS-ELUTING STENTS IN THE RANDOMIZED BIONYX TRIAL

Azygos continuation of the inferior vena cava during transvenous cardiac interventions

Final 5-year report of BIONYX comparing the thin-composite wire-strut zotarolimus-eluting stent versus ultrathin-strut sirolimus-eluting stent

Non-invasive follow-up of a coronary artery pseudoaneurysm after percutaneous transluminal coronary rotational atherectomy (PTCRA)

Outcome after percutaneous coronary intervention with contemporary stents in patients with concomitant peripheral arterial disease: A patient-level pooled analysis of four randomized trials

Impact of chronic kidney disease on left atrial appendage occlusion for stroke prevention in patients with atrial fibrillation

Novel Supreme Drug-Eluting Stents With Early Synchronized Antiproliferative Drug Delivery to Inhibit Smooth Muscle Cell Proliferation After Drug-Eluting Stents Implantation in Coronary Artery Disease: Results of the PIONEER III Randomized Clinical Trial

Hemolysis after percutaneous paravalvular leak repair

Risk of bleeding after percutaneous coronary intervention and its impact on further adverse events in clinical trial participants with comorbid peripheral arterial disease

Suchergebnisse filtern